 BILLERICA, Mass.--BUSINESS WIRE--Quanterix Corporation Nasdaq: QTRX, a company digitizing biomarker analysis to advance the science of precision health, today announced that it has commenced an underwritten public offering of 200.0 million of its common stock. In connection with the offering, Quanterix intends to grant the underwriters a 30-day option to purchase up to an additional 15 of the shares of common stock at the public offering price less the underwriting discounts and commissio 